KFF Health News contributor Sarah Boden discussed cats and bird flu on KVPR’s “Central Valley Daily” on Feb. 12. Click here to hear Boden on “Central Valley Daily” Read Boden’s “House Cats With Bird Flu Could Pose a Risk to Public Health” KFF Health News South Carolina correspondent Lauren Sausser juxtaposed the increasing trendiness of…
Atria Health launched its partnership model for cardiology practices nationwide this week. Instead of buying and then subsequently owning practices, Atria provides capital, expertise and technology to help cardiologists build independent, physician-led practices. The post Atria Health Launches National Partnership Model to Keep Cardiology Practices Independent appeared first on MedCity News.
Through a new partnership, members of the Midwest Health Purchasers Collaborative can access Vida Health’s obesity care solutions. The post Midwest Health Purchasers Collaborative Taps Vida Health for Obesity Specialty Care appeared first on MedCity News.
I’m on this new podcast from Alex Koshykov – COO @ BeKey.io & Sergei Polevikov, Founder @ wellai.health and author of the rather aggressive and very fun AI Health Uncut. The podcast is called Digital Health Inside Out. The other guest was James Wang, General Partner at Creative Ventures. We got deep into the topic…
Check out news from Oral Genome, Junevity, Coral, Keragon, and more. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.
Fans of the Philadelphia Eagles are celebrating their team’s Super Bowl victory with a parade today. They beat the Kansas City Chiefs, which is great for the City of Brotherly Love and obviously a bummer to us here in Missouri. But there’s actually some ambivalence about the parade’s absence in Kansas City. The celebration of…
Jing Wang, Ph.D., M.P.H., R.N., dean of the FSU nursing school, says that nurses are key to successful health system AI implementations
On Friday, the White House announced that it was slashing one-tenth of the CDC workforce
Bristol Myers Squibb’s Opdualag paired with blockbuster immunotherapy Opdivo failed a clinical trial testing the regimen as an adjuvant therapy for patients whose melanoma has been surgically removed. While Opdualag is still projected to reach blockbuster status, it could face competition from a Regeneron Pharmaceuticals drug. The post Bristol Myers Squibb Cancer Immunotherapy Flunks a…
Sonya Stokes, an emergency room physician in the San Francisco Bay Area, braces herself for a daily deluge of patients sick with coughs, soreness, fevers, vomiting, and other flu-like symptoms. She’s desperate for information, but the Centers for Disease Control and Prevention, a critical source of urgent analyses of the flu and other public health…